# Stonehenge Capital: portfolio, investments and team

> Stonehenge Capital is an investment firm based in United States. 22 investments on record, latest Jun 2014. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/stonehenge-capital (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Stonehenge Capital

Filed with the SEC to raise a fund in May 2024, closing $15M. Last cheque observed Jun 2014.

Quiet New fund $15M, May 2024 Investment firm

Series A Venture Series B Information Technology Web Hosting Financial Services

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 22 on record

Since the last cheque **4528** days **00** hrs **00** min **00** sec

Median round **$4.1M** Rounds led **0 of 22** Exits **3 from the portfolio** Mostly in **United States, 100%**

Pitch Stonehenge Capital

## Stonehenge Capital highlights

- 01 22 rounds on record
- 02 Mostly Series A and Venture: 82% of its rounds
- 03 3 exits from the portfolio

## What they do

- **Type:** Investment firm (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Information Technology Web Hosting Financial Services
- **Based in:** Baton Rouge, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **22 appearances**

- **2014** 2 rounds
- **Jun** **[SmartPay Solutions](https://millionrounds.com/company/smartpay-solutions)** Series A · US **$1.4M** With 2 others
- **Jan** **[iDevices](https://millionrounds.com/company/idevices)** Venture · US **$4.3M** With 1 other
- **2013** 1 round
- **Nov** **[Hospicelink](https://millionrounds.com/company/hospicelink)** Series B · US · finsmes.com **Undisclosed** With 2 others
- **2012** 1 round
- **Sept** **[ContinuumRx](https://millionrounds.com/company/continuumrx)** Venture · US · finsmes.com **$7.0M** With 3 others
- **2011** 1 round
- **Aug** **[Thetis Pharmaceuticals](https://millionrounds.com/company/thetis-pharmaceuticals)** Seed · US · masshightech.com **$1.7M** With 1 other
- **2010** 1 round
- **Mar** **[eHealth Technologies™](https://millionrounds.com/company/ehealth-technologies)** Venture · US **$2.5M** With 1 other
- **2008** 1 round
- **Dec** **[SensorTran](https://millionrounds.com/company/sensortran)** Venture · US · austinstartup.com **$3.5M** With 3 others
- **2007** 2 rounds
- **Dec** **[SensorTran](https://millionrounds.com/company/sensortran)** Series B · US · encyclopedia.com **$8.0M** With 3 others
- **Aug** **[Quest Global Manufacturing](https://millionrounds.com/company/quest-global-manufacturing)** Venture · US **$5.0M** With 1 other
- **2006** 5 rounds
- **Nov** **[iCardiac Technologies](https://millionrounds.com/company/icardiac-technologies)** Series A · US **$4.0M** With 1 other
- **Oct** **[PixFusion](https://millionrounds.com/company/pixfusion)** Venture **$4.2M** With 1 other
- **Aug** **[SensorTran](https://millionrounds.com/company/sensortran)** Series A · US **$5.5M** With 2 others
- **Jul** **[Infrastruct Security](https://millionrounds.com/company/infrastruct-security)** Series A · US **$4.0M** With 2 others
- **Jan** **[EraGen Biosciences](https://millionrounds.com/company/eragen-biosciences)** Series A · US · eragen.com **$12M** With 3 others
- **2005** 2 rounds
- **Dec** **[Lumetrics](https://millionrounds.com/company/lumetrics)** Series A · US · newyorkphotonics.org **$1.3M** With 1 other
- **Jan** **[OpGen](https://millionrounds.com/company/opgen)** Series B · US **$5.0M** With 3 others
- **2004** 5 rounds
- **Dec** **[Zystor](https://millionrounds.com/company/zystor)** Series A · US **$8.5M** With 6 others
- **Oct** **[Critical Mention](https://millionrounds.com/company/critical-mention)** Series A · US **$2.0M** With 4 others
- **Mar** **[Alinean](https://millionrounds.com/company/alinean)** Series A · US **Undisclosed** With 1 other
- **Jan** **[D’Lisi Food Systems](https://millionrounds.com/company/d-lisi-food-systems)** Venture · US **$4.2M** With 2 others
- **Jan** **[Critical Media](https://millionrounds.com/company/critical-media)** Series A · US · demo.com **$2.0M** With 3 others
- **2002** 1 round
- **Nov** **[Knovel](https://millionrounds.com/company/knovel)** Venture · US · publishersweekly.com **$3.0M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **4 named**

BG **Barry G. Gowdy** Executive Officer i Filing they signed

JS **Joel S. Boussert** Executive Officer, Director i Filing they signed

KK **Kent K. Rinker** Director i Filing they signed

TJ **Thomas J. Adamek** Executive Officer, Director i Filing they signed

We also hold **43** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **3 in all**

**[Knovel](https://millionrounds.com/company/knovel)** Bought by Elsevier **Undisclosed** Jan 2013

**[EraGen Biosciences](https://millionrounds.com/company/eragen-biosciences)** Bought by Luminex **$34M** Jun 2011

**[Zystor](https://millionrounds.com/company/zystor)** Bought by BioMarin Pharmaceutical **$115M** Aug 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**$15M**

raised in May 2024

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Series A Venture Series B

Median round joined **$4.1M** the round, not its cheque

Led 0 of 22 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Jun 2014
- **Exits:** 3 from the portfolio

Rounds by stage said on their site

- Series A *10*
- Venture *8*
- Series B *3*
- Seed *1*

Cheques by year Led Joined

2002 2014

Often in the room with

- [Advantage Capital](https://millionrounds.com/fund/advantage-capital) 4
- [Connecticut Innovations](https://millionrounds.com/fund/connecticut-innovations) 3
- [Expansion Capital Partners](https://millionrounds.com/fund/expansion-capital-partners) 3
- [Silicon Alley Venture Partners](https://millionrounds.com/fund/silicon-alley-venture-partners) 3
- [WHEB Partners](https://millionrounds.com/fund/wheb-partners) 3
- [Declaration Partners](https://millionrounds.com/fund/declaration-partners) 2

**Pitching Stonehenge Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Stonehenge Capital. A count of rooms they were both in, not a relationship either has claimed.

[**Advantage Capital** Corporate VC **4** rounds together](https://millionrounds.com/fund/advantage-capital)[**Connecticut Innovations** Government **3** rounds together](https://millionrounds.com/fund/connecticut-innovations)[**Expansion Capital Partners** Investment firm **3** rounds together](https://millionrounds.com/fund/expansion-capital-partners)[**Silicon Alley Venture Partners** VC firm **3** rounds together](https://millionrounds.com/fund/silicon-alley-venture-partners)[**WHEB Partners** Investment firm **3** rounds together](https://millionrounds.com/fund/wheb-partners)[**Declaration Partners** Family office **2** rounds together](https://millionrounds.com/fund/declaration-partners)[**Mason Wells Biomediacl Fund** Growth equity **2** rounds together](https://millionrounds.com/fund/mason-wells-biomediacl-fund)[**Milestone Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/milestone-venture-partners)[**Prolog Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/prolog-ventures)[**State of Wisconsin Investment Board** Investment firm **2** rounds together](https://millionrounds.com/fund/state-of-wisconsin-investment-board)

## Quick answers about Stonehenge Capital

### What does Stonehenge Capital invest in?

Stonehenge Capital invests most often at Series A and Venture (82% of the rounds on record), in sectors such as Information Technology, Web Hosting and Financial Services.

### How active is Stonehenge Capital?

22 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2014.

### How big are Stonehenge Capital's cheques?

The median round it joins is $4.1M.

### Does Stonehenge Capital lead rounds?

Rarely, if at all: none of its 22 investments on record names it as the lead.

### Where does Stonehenge Capital invest?

Most of the companies it backs are in the United States (100%).

### Is Stonehenge Capital investing now?

No investments in the last 12 months; the latest was in Jun 2014.

### Who does Stonehenge Capital invest alongside?

Most often Advantage Capital (4 rounds together), Connecticut Innovations (3 rounds together) and Expansion Capital Partners (3 rounds together).

### What kind of investor is Stonehenge Capital?

Stonehenge Capital is an investment firm based in Baton Rouge, United States.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=stonehenge-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=stonehenge-capital)
